This study showed that LUAD, KIRC and LIHC patients with low VIPR1 expression had poor prognosis (Supplementary Figure S2A), which was consistent with the findings in liver cancer and cervical cancer (Kim et al., 2013; Lu et al., 2019). This evidence concerns the gene VIPR1 and cervical carcinoma.